The company’s CEO-to-employee pay ratio was 389:1 in 2023, according to regulatory documents the company filed March 29.
Here were the company’s five highest-paid executives in 2023:
President and CEO Gail Boudreaux
- Salary: $1,600,000
- Stock awards: $11,850,043
- Option awards: $3,950,036
- Non-equity incentive plan: $3,648,000
- Other compensation: $840,960
- Total compensation: $21,889,039
CFO Mark Kaye
- Salary: $252,692
- Stock awards: $10,775,411
- Option awards: $924,613
- Non-equity incentive plan: $351,748
- Other compensation: $54,737
- Total compensation: $12,359,201
Chief Legal and Administrative Officer Blair Todt
- Salary: $833,846
- Stock awards: $5,000,648
- Option awards: $999,708
- Non-equity incentive plan: $1,155,711
- All other compensation: $123,059
- Total compensation: $8,112,972
President of Carelon and CarelonRx Peter Haytaian
- Salary: $944,231
- Stock awards: $3,225,051
- Option awards: $1,074,976
- Non-equity incentive plan: $1,314,369
- Other compensation: $419,424
- Total: $6,978,051
President of Government Health Benefits Felicia Norwood
- Salary: $944,231
- Stock awards: $3,225,051
- Option awards: $1,074,976
- Non-equity incentive plan: $1,087,754
- Other compensation: $143,396
- Total: $6,475,408
Former CFO John Gallina was also among the Elevance Health’s highest paid executives in 2023. He was paid $8.2 million in total compensation in 2023. Mr. Gallina retired from the CFO role Nov. 1 and remains a special adviser to the CEO.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
